# Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

> **NCT00620451** · PHASE2 · COMPLETED · sponsor: **9 Meters Biopharma, Inc.** · enrollment: 105 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** larazotide acetate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00620451
- **Lead sponsor:** 9 Meters Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-12
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2017-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620451, "Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00620451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*